Bleichroeder’s Opus Genetics IRD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRD
AIC
Bleichroeder's IRD Position: Q3 2026 in Review
Bleichroeder reduced its Opus Genetics (IRD) stake by 68% in Q3 2026, selling an estimated $2.08M and leaving 236,842 shares worth $1.15M. The position accounts for 0.11% of the portfolio, ranked #71.
Bleichroeder first reported a position in IRD in Q1 2025 and has held it in 7 quarters since. The position peaked at $3.35M in Q1 2026. 74 funds tracked by Wall St. Rank hold IRD as of Q3 2026.
- Bleichroeder held 236,842 shares of Opus Genetics worth $1.15M as of Q3 2026.
- Bleichroeder sold 500,000 Opus Genetics shares in Q3 2026, an estimated $2.08M.
- Opus Genetics made up 0.11% of Bleichroeder's portfolio in Q3 2026, its #71 holding.
- Bleichroeder first reported a position in Opus Genetics in Q1 2025 and has held it in 7 quarters since.
- Bleichroeder's Opus Genetics position peaked at $3.35M in Q1 2026.
- 74 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2026.
Based on Bleichroeder's 13F filing for Q3 2026, filed 13 Nov 2026.